Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers

Podobne zapisy

• Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers.
  od: Ann J Hessell, i wsp.
  Wydane: (2009-05-01)
• Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIV(Ba-L)
  od: Hessell, Ann J., i wsp.
  Wydane: (2010)
• EFFECTIVE, LOW TITER, ANTIBODY PROTECTION AGAINST LOW-DOSE REPEATED MUCOSAL SHIV CHALLENGE IN MACAQUES
  od: Hessell, Ann J., i wsp.
  Wydane: (2009)
• T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers
  od: Arunachalam, Prabhu S., i wsp.
  Wydane: (2020)
• Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
  od: Burton, Dennis R., i wsp.
  Wydane: (2016)